Dermata Therapeutics, Inc.
DRMA
$0.8721
-$0.0358-3.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.15M | -3.17M | -2.83M | -3.13M | -2.13M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.80K | 21.00K | 19.60K | 587.20K | 128.50K |
| Change in Net Operating Assets | 207.50K | -266.80K | 683.50K | -157.40K | 858.20K |
| Cash from Operations | -2.91M | -3.42M | -2.13M | -2.70M | -1.15M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 4.55M | 2.41M | -- | 1.95M |
| Repurchase of Common Stock | -68.60K | 0.00 | -800.00 | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 70.00K | -70.00K | -- | -- |
| Cash from Financing | -68.60K | 4.62M | 2.34M | -- | 1.95M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.98M | 1.20M | 213.40K | -2.70M | 806.70K |